This complex interaction among inflammatory responses, oxidative stress, programmed cell death, altered mitochondrial dynamics, MAPK signaling, and Akt activation suggests the need for a multifaceted therapeutic approach to achieve neuroprotection and enhance recovery after an ischemic stroke. The gene discussed is AKT1; the disease is ischemic stroke.